Drymel, B.; Tomela, K.; Galus, Ł.; Olejnik-Schmidt, A.; Mackiewicz, J.; Kaczmarek, M.; Mackiewicz, A.; Schmidt, M.
Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients. Int. J. Mol. Sci. 2024, 25, 12982.
https://doi.org/10.3390/ijms252312982
AMA Style
Drymel B, Tomela K, Galus Ł, Olejnik-Schmidt A, Mackiewicz J, Kaczmarek M, Mackiewicz A, Schmidt M.
Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients. International Journal of Molecular Sciences. 2024; 25(23):12982.
https://doi.org/10.3390/ijms252312982
Chicago/Turabian Style
Drymel, Bernadeta, Katarzyna Tomela, Łukasz Galus, Agnieszka Olejnik-Schmidt, Jacek Mackiewicz, Mariusz Kaczmarek, Andrzej Mackiewicz, and Marcin Schmidt.
2024. "Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients" International Journal of Molecular Sciences 25, no. 23: 12982.
https://doi.org/10.3390/ijms252312982
APA Style
Drymel, B., Tomela, K., Galus, Ł., Olejnik-Schmidt, A., Mackiewicz, J., Kaczmarek, M., Mackiewicz, A., & Schmidt, M.
(2024). Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients. International Journal of Molecular Sciences, 25(23), 12982.
https://doi.org/10.3390/ijms252312982
